ORBERA INTRAGASTRIC BALLOON

Implant, Intragastric For Morbid Obesity

FDA Premarket Approval P140008

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the orbera intragastric balloon. The orbera intragastric balloon system is indicated for use as an adjunct to weight reduction for adults with obesity with body mass index (bmi) of >= 30 and

DeviceORBERA INTRAGASTRIC BALLOON
Classification NameImplant, Intragastric For Morbid Obesity
Generic NameImplant, Intragastric For Morbid Obesity
ApplicantAPOLLO ENDOSURGERY INC
Date Received2014-04-29
Decision Date2015-08-05
Notice Date2015-08-06
PMAP140008
SupplementS
Product CodeLTI
Docket Number15M-2964
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address APOLLO ENDOSURGERY INC 1120 S Capital Of Tx Hwy bldg 1, Ste 300 austin, TX 78746-0000
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140008Original Filing
S024 2022-07-11 Real-time Process
S023 2021-12-06 30-day Notice
S022 2021-05-19 Real-time Process
S021 2020-09-18 Special (immediate Track)
S020
S019
S018 2019-06-24 30-day Notice
S017 2019-03-04 Special (immediate Track)
S016
S015
S014 2018-10-02 Normal 180 Day Track No User Fee
S013 2018-06-12 Normal 180 Day Track No User Fee
S012 2018-05-01 Special (immediate Track)
S011 2017-12-27 Special (immediate Track)
S010
S009
S008 2017-11-06 135 Review Track For 30-day Notice
S007 2017-05-25 Normal 180 Day Track No User Fee
S006 2017-05-08 Special (immediate Track)
S005 2017-04-12 30-day Notice
S004
S003 2015-09-18 Normal 180 Day Track No User Fee
S002 2015-09-03 Normal 180 Day Track No User Fee
S001 2015-08-31 135 Review Track For 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.